![Alan I. Annex](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan I. Annex
Direktor/Vorstandsmitglied bei Merand Pharmaceuticals, Inc.
Profil
Alan I.
Annex has worked as a Secretary, Director & Vice President at Merand Pharmaceuticals, Inc. and has also worked at Greenberg Traurig LLP.
Aktive Positionen von Alan I. Annex
Unternehmen | Position | Beginn |
---|---|---|
Merand Pharmaceuticals, Inc.
![]() Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Merand Pharmaceuticals, Inc.
![]() Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Health Technology |